Israel - English - Ministry of Health

lundbeck israel ltd - flupentixol as dihydrochloride - tablets - flupentixol as dihydrochloride 3 mg - flupentixol - flupentixol - schizophrenia, mania.

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - drospirenone micronized ethinylestradiol (as betadex clathrate micronized) - film coated tablet - 0.02/3 milligram

Malta - English - Medicines Authority

bayer limited 1st floor the grange offices the grange brewery road stillorgan co. dublin, a94 h2k7 , ireland - drospirenone, ethinylestradiol - film-coated tablet - ethinylestradiol 0.02 mg drospirenone 3 mg - sex hormones and modulators of the genital system

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - aspirin, quantity: 100.008 mg - tablet, enteric coated - excipient ingredients: sunset yellow fcf aluminium lake; carbomer 941; purified talc; citric acid; macrogol 6000; pregelatinised maize starch; sodium hydroxide; stearic acid; methacrylic acid copolymer; hypromellose; titanium dioxide; purified water; maize starch; microcrystalline cellulose; betadex; xanthan gum; polyvinyl alcohol; lecithin - for the treatment of patients with known cardiovascular or cerebrovascular disease an antiplatelet agent for prophylaxis against acute myocardial infarction, unstable angina, transient ischaemic attack and cerebrovascular accident (stroke)

Australia - English - Department of Health (Therapeutic Goods Administration)

sigma company limited - aspirin, quantity: 100.008 mg - tablet, enteric coated - excipient ingredients: citric acid; microcrystalline cellulose; purified water; titanium dioxide; carbomer 941; sodium hydroxide; pregelatinised maize starch; maize starch; stearic acid; betadex; macrogol 6000; sunset yellow fcf aluminium lake; purified talc; methacrylic acid copolymer; hypromellose; xanthan gum; polyvinyl alcohol; lecithin - for the treatment of patients with known cardiovascular or cerebrovascular disease an antiplatelet agent for prophylaxis against acute myocardial infarction, unstable angina, transient ischaemic attack and cerebrovascular accident (stroke)

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - voriconazole, quantity: 50 mg - tablet, film coated - excipient ingredients: povidone; lactose monohydrate; colloidal anhydrous silica; croscarmellose sodium; pregelatinised maize starch; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000 - voriconazole is indicated for treatment of the following fungal infections:,invasive aspergillosis.,serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,serious fungal infections caused by scedosporium spp and fusarium spp.,other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - voriconazole, quantity: 200 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; pregelatinised maize starch; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; macrogol 4000 - voriconazole is indicated for treatment of the following fungal infections:,invasive aspergillosis.,serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,serious fungal infections caused by scedosporium spp and fusarium spp.,other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - aspirin, quantity: 100.008 mg - tablet, enteric coated - excipient ingredients: sunset yellow fcf aluminium lake; citric acid; purified water; stearic acid; betadex; maize starch; pregelatinised maize starch; titanium dioxide; macrogol 6000; purified talc; methacrylic acid copolymer; sodium hydroxide; microcrystalline cellulose; hypromellose; carbomer 941; xanthan gum; polyvinyl alcohol; lecithin - for the treatment of patients with known cardiovascular or cerebrovascular disease an antiplatelet agent for prophylaxis against acute myocardial infarction, unstable angina, transient ischaemic attack and cerebrovascular accident (stroke)

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - aspirin, quantity: 100.008 mg - tablet, enteric coated - excipient ingredients: betadex; sodium hydroxide; sunset yellow fcf aluminium lake; macrogol 6000; purified water; microcrystalline cellulose; purified talc; citric acid; carbomer 941; titanium dioxide; hypromellose; methacrylic acid copolymer; stearic acid; pregelatinised maize starch; maize starch; xanthan gum; polyvinyl alcohol; lecithin - for the treatment of patients with known cardiovascular or cerebrovascular disease, as an antiplatelet agent for prophylaxis against acute myocardial infarction, unstable angina, transient ischaemic attack and cerebrovascular accident (stroke).

Canada - English - Health Canada

lundbeck canada inc - flupentixol decanoate - solution - 20mg - flupentixol decanoate 20mg - thioxanthenes